查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945426

2026年全球靜脈輸液治療解決方案市場報告

Intravenous Therapy Solutions Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，靜脈輸液市場發展迅速，預計將從2025年的131.7億美元成長到2026年的145.3億美元，複合年成長率（CAGR）為10.3%。過去幾年的成長可歸因於多種因素，例如醫院基礎設施的擴建、脫水和電解質失衡的患病率上升、靜脈輸液療法在臨床上的應用日益廣泛、靜脈輸液技術的進步以及外科手術數量的增加。

預計未來幾年，靜脈輸液治療市場將強勁成長，2030年市場規模將達212.5億美元，複合年成長率（CAGR）為10.0%。預測期內的成長要素包括：居家醫療的日益普及、對個人化營養和藥物管理需求的成長、與數位健康平台的技術整合、新興市場的擴張以及慢性病管理技術的進步。預測期內的主要趨勢包括：個人化靜脈輸液治療方案、攜帶式和家用靜脈注射設備、感染控制和安全性的提升、先進的電解質和營養配方以及與電子健康記錄（EHR）的整合。

預計對微創手術日益成長的需求將推動靜脈輸液治療市場的成長。微創手術是指對身體切口或侵入量極小的醫療程序，通常可縮短恢復時間並減少併發症。這種成長趨勢源自於微創手術的特性，這些手術能夠減輕術後疼痛、加速恢復速度並提高患者在復原過程中的舒適度。靜脈輸液治療透過將液體、藥物和營養物質直接輸送到血液中，從而實現這些治療，有助於提高患者照護效果並加速康復。例如，根據美國整形外科醫師協會2024年6月發布的數據，2023年微創手​​術的數量年增7%，比外科手術的整體成長率高出2%。因此，對微創手術日益成長的需求正在推動靜脈輸液治療市場的成長。

靜脈輸液治療市場的主要企業正致力於開發創新產品，例如即用型輸液，以提高治療效率並縮短臨床環境中的配藥時間。即用型輸液是預先混合、預先貼標的靜脈注射藥物，以標準化劑量包裝，無需現場稀釋或配製。 2024年5月，美國製造商貝朗醫療公司（B. Braun Medical Inc.）推出了“氯化鈉注射液中的左乙拉西坦”，這是一種用於治療癲癇發作的即用型靜脈抗驚厥溶液。該產品以標準化的濃度和容量提供，無需在照護端進行稀釋或配製。該製劑預先混合在軟性容器中，確保劑量準確並降低污染風險，從而為急診和住院患者照護環境中的醫護人員帶來便利。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球靜脈輸液治療方案市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
    • 永續性、氣候技術和循環經濟
  • 主要趨勢
    • 個人化靜脈輸液治療方案
    • 攜帶式和家用輸液裝置
    • 感染控制和安全改進
    • 高級電解質和營養配方
    • 電子健康記錄 (EHR) 整合

第5章 終端用戶產業市場分析

  • 醫院
  • 診所
  • 門診手術中心
  • 居家醫療機構
  • 專業醫療中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球靜脈輸液治療解決方案市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球靜脈輸液治療解決方案市場規模、對比及成長率分析
  • 全球靜脈輸液治療解決方案市場表現：規模與成長，2020-2025年
  • 全球靜脈輸液治療解決方案市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品類型
  • 晶體液、膠體液、血液製品及其他產品類型
  • 透過使用
  • 體液和電解質失衡、營養支持、藥物輸注、輸血及其他用途
  • 最終用戶
  • 醫院、診所、門診手術中心、居家醫療機構和其他最終用戶
  • 按類型細分：晶體溶液
  • 生理食鹽水水（0.9%氯化鈉溶液）、半體積生理食鹽水（0.45%氯化鈉溶液）、乳酸林格氏液、葡萄糖溶液、高滲透壓鹽水
  • 按類型細分：膠體製劑
  • 白蛋白、聚葡萄糖、羥乙基澱粉（HES）、明膠
  • 按類型細分：血液製品
  • 濃縮紅血球（PRBC）、血小板、新鮮冷凍血漿（FFP）、冷沉澱
  • 按類型細分：其他產品類型
  • 靜脈注射免疫球蛋白（IVIG）、腸外營養、特殊靜脈注射藥物及添加劑

第10章 區域與國家分析

  • 全球靜脈輸液市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球靜脈輸液治療解決方案市場：國家/地區、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 靜脈輸液治療方案市場：競爭格局及市場佔有率（2024年）
  • 靜脈輸液治療方案市場：公司估值矩陣
  • 靜脈輸液治療方案市場：公司概況
    • Pfizer Inc.
    • Otsuka Pharmaceutical Co. Ltd.
    • Baxter International Inc.
    • Fresenius Kabi AG
    • Grifols SA

第37章：其他領先和創新企業

  • Terumo Corporation, Dr. Reddy's Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited, Amanta Healthcare Limited, Aculife Healthcare Private Limited, Claris Lifesciences Limited

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年靜脈輸液治療市場：提供新機會的國家
  • 2030年靜脈輸液治療市場：新興細分市場機會
  • 2030年靜脈輸液治療市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MITSH01_G26Q1

Intravenous therapy solutions are sterile liquid formulations administered directly into the bloodstream to deliver fluids, medications, nutrients, or electrolytes. These solutions are used to treat conditions such as dehydration, electrolyte imbalances, infections, and to provide essential nutrients when oral intake is not feasible. Typically composed of water, salts, sugars, or medicinal ingredients, they are customized based on individual patient requirements and specific medical conditions.

The primary types of intravenous therapy solutions include crystalloids, colloids, blood products, and others. Crystalloids consist of water mixed with electrolytes and are commonly used for rapid rehydration and fluid balance restoration in urgent medical situations. These solutions serve multiple purposes, including correcting fluid and electrolyte imbalances, supporting nutrition, administering medications, and enabling blood transfusions. They are utilized across a range of healthcare settings, including hospitals, clinics, ambulatory surgical centers, home care environments, and more.

Tariffs are impacting the intravenous therapy solutions market by increasing the cost of imported raw materials such as saline, glucose, and specialty nutrients, leading to higher production costs for manufacturers. The segments most affected include crystalloids and colloids, particularly in regions like North America and Europe, which rely on imports from Asia-Pacific. While tariffs have posed challenges in supply chain efficiency, they have also encouraged local manufacturing and innovation, creating opportunities for domestic production of cost-effective intravenous solutions.

The intravenous therapy solutions market research report is one of a series of new reports from The Business Research Company that provides intravenous therapy solutions market statistics, including intravenous therapy solutions industry global market size, regional shares, competitors with a intravenous therapy solutions market share, detailed intravenous therapy solutions market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous therapy solutions industry. This intravenous therapy solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous therapy solutions market size has grown rapidly in recent years. It will grow from $13.17 billion in 2025 to $14.53 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to growing hospital infrastructure, rising incidence of dehydration and electrolyte imbalance, increasing adoption of iv therapy in clinics, technological advancements in iv solutions, rising surgical procedures.

The intravenous therapy solutions market size is expected to see strong growth in the next few years. It will grow to $21.25 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing home healthcare adoption, rising demand for personalized nutrition and medication administration, technological integration with digital health platforms, expansion in emerging markets, growth in chronic disease management. Major trends in the forecast period include personalized iv therapy solutions, portable and home-based iv devices, infection control and safety enhancements, advanced electrolyte and nutrient formulations, integration with electronic health records (ehr).

The increasing demand for minimally invasive therapies is expected to drive growth in the intravenous therapy solutions market. Minimally invasive therapies involve medical treatments with minimal incisions or bodily entry, often resulting in quicker recovery and fewer complications. This rising preference is attributed to the therapies' ability to reduce postoperative pain, leading to faster recovery and greater patient comfort during healing. Intravenous therapy solutions facilitate these treatments by delivering fluids, medications, and nutrients directly into the bloodstream, promoting effective patient care and accelerated recovery. For example, in June 2024, the American Society of Plastic Surgeons reported that minimally invasive procedures increased by 7% in 2023, surpassing the growth rate of surgical procedures by 2%. Hence, the rising demand for minimally invasive therapies is fueling the expansion of the intravenous therapy solutions market.

Key players in the intravenous therapy solutions market are focusing on innovative products such as ready-to-use drug infusions to improve treatment efficiency and reduce preparation time in clinical environments. Ready-to-use drug infusions consist of pre-mixed and pre-labeled intravenous medications packaged in standardized doses, eliminating the need for on-site dilution or compounding. In May 2024, B. Braun Medical Inc., a US-based manufacturer, introduced Levetiracetam in Sodium Chloride Injection, a ready-to-use intravenous anticonvulsant solution designed for seizure treatment. This product comes in standardized concentrations and volumes, removing the requirement for dilution or compounding at the point of care. The formulation is pre-mixed in a flexible container to ensure dosing accuracy, reduce contamination risks, and improve convenience for healthcare providers in emergency and inpatient settings.

In April 2025, Organon & Co., a US-based healthcare company, acquired the regulatory and commercial rights to Tofidence from Biogen Inc. This acquisition aims to strengthen and expand Organon & Co.'s biosimilars immunology portfolio in the US by including Tofidence to support treatments for multiple arthritis conditions and COVID-19. The company plans to leverage its commercial expertise and market access capabilities to foster long-term growth in the immunology sector. Biogen Inc. is a US-based biotechnology firm specializing in intravenous therapy solutions like Tofidence.

Major companies operating in the intravenous therapy solutions market are Pfizer Inc., Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy's Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited, Amanta Healthcare Limited, Aculife Healthcare Private Limited, Claris Lifesciences Limited, Osel Lifesciences Pvt. Ltd., BBraun Avitum AG

North America was the largest region in the intravenous therapy solutions market in 2025. The regions covered in the intravenous therapy solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intravenous therapy solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The intravenous therapy solutions market consists of sales of saline solutions, dextrose solutions, lactated Ringer's solutions, amino acid solutions, vitamin and mineral infusions, IV antibiotic solutions, chemotherapy IV solutions, and parenteral nutrition solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous Therapy Solutions Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses intravenous therapy solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous therapy solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous therapy solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Crystalloids; Colloids; Blood Products; Other Product Types
  • 2) By Application: Fluid And Electrolyte Imbalance; Nutritional Support; Medication Administration; Blood Transfusion; Other Applications
  • 3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Home Care Settings; Other End-Users
  • Subsegments:
  • 1) By Crystalloids: Normal Saline (0.9% Sodium Chloride); Half Normal Saline (0.45% Sodium Chloride); Lactated Ringer's Solution; Dextrose Solutions; Hypertonic Saline
  • 2) By Colloids: Albumin; Dextran; Hydroxyethyl Starch (HES); Gelatin
  • 3) By Blood Products: Packed Red Blood Cells (PRBCs); Platelets; Fresh Frozen Plasma (FFP); Cryoprecipitate
  • 4) By Other Product Types: Intravenous Immunoglobulins (IVIG); Parenteral Nutrition Solutions; Specialty Intravenous Drugs And Additives
  • Companies Mentioned: Pfizer Inc.; Otsuka Pharmaceutical Co. Ltd.; Baxter International Inc.; Fresenius Kabi AG; Grifols S.A.; Terumo Corporation; Dr. Reddy's Laboratories Limited; Sichuan Kelun Pharmaceutical Co. Ltd.; Hikma Pharmaceuticals PLC; Biocon Limited; B. Braun Melsungen Aktiengesellschaft; JW Life Science Corporation; AdvaCare Pharma USA; Soxa Formulations & Research Pvt. Ltd.; Vifor Pharma Management Ltd.; Aetos Pharma Private Limited; LXIR Medilabs Private Limited; Amanta Healthcare Limited; Aculife Healthcare Private Limited; Claris Lifesciences Limited; Osel Lifesciences Pvt. Ltd.; BBraun Avitum AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Intravenous Therapy Solutions Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Intravenous Therapy Solutions Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Intravenous Therapy Solutions Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Intravenous Therapy Solutions Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Personalized Iv Therapy Solutions
    • 4.2.2 Portable And Home-Based Iv Devices
    • 4.2.3 Infection Control And Safety Enhancements
    • 4.2.4 Advanced Electrolyte And Nutrient Formulations
    • 4.2.5 Integration With Electronic Health Records (Ehr)

5. Intravenous Therapy Solutions Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Home Care Settings
  • 5.5 Specialty Care Centers

6. Intravenous Therapy Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Intravenous Therapy Solutions Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Intravenous Therapy Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Intravenous Therapy Solutions Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Intravenous Therapy Solutions Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Intravenous Therapy Solutions Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Intravenous Therapy Solutions Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Intravenous Therapy Solutions Market Segmentation

  • 9.1. Global Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Crystalloids, Colloids, Blood Products, Other Product Types
  • 9.2. Global Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fluid And Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, Other Applications
  • 9.3. Global Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Other End-Users
  • 9.4. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Crystalloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Normal Saline (0.9% Sodium Chloride), Half Normal Saline (0.45% Sodium Chloride), Lactated Ringer's Solution, Dextrose Solutions, Hypertonic Saline
  • 9.5. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Colloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Albumin, Dextran, Hydroxyethyl Starch (HES), Gelatin
  • 9.6. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Blood Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Packed Red Blood Cells (PRBCs), Platelets, Fresh Frozen Plasma (FFP), Cryoprecipitate
  • 9.7. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Intravenous Immunoglobulins (IVIG), Parenteral Nutrition Solutions, Specialty Intravenous Drugs And Additives

10. Intravenous Therapy Solutions Market Regional And Country Analysis

  • 10.1. Global Intravenous Therapy Solutions Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Intravenous Therapy Solutions Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Intravenous Therapy Solutions Market

  • 11.1. Asia-Pacific Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Intravenous Therapy Solutions Market

  • 12.1. China Intravenous Therapy Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Intravenous Therapy Solutions Market

  • 13.1. India Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Intravenous Therapy Solutions Market

  • 14.1. Japan Intravenous Therapy Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Intravenous Therapy Solutions Market

  • 15.1. Australia Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Intravenous Therapy Solutions Market

  • 16.1. Indonesia Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Intravenous Therapy Solutions Market

  • 17.1. South Korea Intravenous Therapy Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Intravenous Therapy Solutions Market

  • 18.1. Taiwan Intravenous Therapy Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Intravenous Therapy Solutions Market

  • 19.1. South East Asia Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Intravenous Therapy Solutions Market

  • 20.1. Western Europe Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Intravenous Therapy Solutions Market

  • 21.1. UK Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Intravenous Therapy Solutions Market

  • 22.1. Germany Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Intravenous Therapy Solutions Market

  • 23.1. France Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Intravenous Therapy Solutions Market

  • 24.1. Italy Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Intravenous Therapy Solutions Market

  • 25.1. Spain Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Intravenous Therapy Solutions Market

  • 26.1. Eastern Europe Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Intravenous Therapy Solutions Market

  • 27.1. Russia Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Intravenous Therapy Solutions Market

  • 28.1. North America Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Intravenous Therapy Solutions Market

  • 29.1. USA Intravenous Therapy Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Intravenous Therapy Solutions Market

  • 30.1. Canada Intravenous Therapy Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Intravenous Therapy Solutions Market

  • 31.1. South America Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Intravenous Therapy Solutions Market

  • 32.1. Brazil Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Intravenous Therapy Solutions Market

  • 33.1. Middle East Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Intravenous Therapy Solutions Market

  • 34.1. Africa Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Intravenous Therapy Solutions Market Regulatory and Investment Landscape

36. Intravenous Therapy Solutions Market Competitive Landscape And Company Profiles

  • 36.1. Intravenous Therapy Solutions Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Intravenous Therapy Solutions Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Intravenous Therapy Solutions Market Company Profiles
    • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Intravenous Therapy Solutions Market Other Major And Innovative Companies

  • Terumo Corporation, Dr. Reddy's Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited, Amanta Healthcare Limited, Aculife Healthcare Private Limited, Claris Lifesciences Limited

38. Global Intravenous Therapy Solutions Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Intravenous Therapy Solutions Market

40. Intravenous Therapy Solutions Market High Potential Countries, Segments and Strategies

  • 40.1 Intravenous Therapy Solutions Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Intravenous Therapy Solutions Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Intravenous Therapy Solutions Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer